Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review
- 30 July 2020
- journal article
- review article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 20 (1), e1-e4
- https://doi.org/10.1016/j.clcc.2020.07.007
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30 CA006927)
This publication has 42 references indexed in Scilit:
- Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphomaBlood, 2011
- Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOXOncology, 2010
- Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literatureJournal of Hematology & Oncology, 2010
- Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 StudyJournal of Clinical Oncology, 2009
- Oxaliplatin-induced allergic reaction in patients with colorectal cancer in JapanInternational Journal of Clinical Oncology, 2009
- Allergic Reactions to Oxaliplatin in a Single Institute in JapanJapanese Journal of Clinical Oncology, 2009
- Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and managementJournal of Thrombosis and Haemostasis, 2009
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200Journal of Clinical Oncology, 2007
- Allergic-type reactions to oxaliplatin: Retrospective analysis of 42 patientsEuropean Journal of Cancer, 2005